OPKO HEALTH INC
OPKO HEALTH INC
Share · US68375N1037 · OPK · A0MUUJ (XNAS)
Overview Financial Indicators
1,36 USD
-0,73 % -0,01 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 21:56

Current Prices from OPKO HEALTH INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
OPK
USD
06.06.2025 21:56
1,36 USD
1,37 USD
-0,73 %
XLON: London
London
0KCS.L
USD
06.06.2025 14:16
1,37 USD
1,37 USD
+0,04 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,00 % 7,09 % -28,04 % -14,47 % 1,49 % -42,13 %

Company Profile for OPKO HEALTH INC Share

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

Company Data

Name OPKO HEALTH INC
Company OPKO Health, Inc.
Symbol OPK
Website https://www.opko.com
Primary Exchange XNAS NASDAQ
WKN A0MUUJ
ISIN US68375N1037
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Dr. Phillip Frost Ph.D.
Market Capitalization 960 Mio
Country United States of America
Currency USD
Employees 3,0 T
Address 4400 Biscayne Boulevard, 33137 Miami
IPO Date 2018-01-29

ID Changes

Date From To
13.06.2007 EXEG OPK

Ticker Symbols

Name Symbol
Frankfurt XCY.F
London 0KCS.L
NASDAQ OPK

More Shares

Investors who OPKO HEALTH INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
AVIATION CAP 25/27 REGS
AVIATION CAP 25/27 REGS Bond
BIOGEN INC
BIOGEN INC Share
BNPP EURO MID CAP CCL
BNPP EURO MID CAP CCL Fund
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DK.ENY.CARO. 19/49
DK.ENY.CARO. 19/49 Bond
EBAY INC
EBAY INC Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Share
WACKER NEUSON SE
WACKER NEUSON SE Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025